Your browser doesn't support javascript.
loading
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases.
Visentin, Andrea; Imbergamo, Silvia; Frezzato, Federica; Pizzi, Marco; Bertorelle, Roberta; Scomazzon, Edoardo; Berno, Tamara; Riva, Marcello; Piva, Elisa; Facco, Monica; Piazza, Francesco; Semenzato, Gianpietro; Trentin, Livio.
Afiliación
  • Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Imbergamo S; Venetian Institute of Molecular Medicine, Centro di Eccellenza per la Ricerca Biomedica Avanzata, Padua, Italy.
  • Frezzato F; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Pizzi M; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Bertorelle R; Venetian Institute of Molecular Medicine, Centro di Eccellenza per la Ricerca Biomedica Avanzata, Padua, Italy.
  • Scomazzon E; General Pathology and Cytopathology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Berno T; Immunology and Molecular Diagnostic Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.
  • Riva M; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Piva E; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Facco M; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Piazza F; Unity of Laboratory Medicine, University of Padua, Padua, Italy.
  • Semenzato G; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Trentin L; Venetian Institute of Molecular Medicine, Centro di Eccellenza per la Ricerca Biomedica Avanzata, Padua, Italy.
Oncotarget ; 8(66): 110727-110731, 2017 Dec 15.
Article en En | MEDLINE | ID: mdl-29299182

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Italia